logo

For the Inventor, By the Inventor

Hyderabad Telangana, India

Suresh Paidakula

This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2013-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suresh Paidakula. Retrieved from https://idiyas.com/inventor/suresh-paidakula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 25.0

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Andhra Pradesh, IN (2013)
  • Hyderabad, IN (2014 - 2015)

Company Filing History:

goldMedal4 out of 2,130 
 
Council of Scientific and Industrial Research
 patents

Years Active: 2013-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 9102638 - Amidobenzothiazoles and process for the preparation thereof (2015-08-11),
2. 8927560 - 4-Aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof (2015-01-06),
3. 8673969 - Substituted 4-β-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof (2014-03-18),
4. 8354547 - 4β-amino podophyllotoxin congeners as anti tumour antibiotics a process for the preparation thereof (2013-01-15),

Title: Suresh Paidakula: Innovator in Anti-Cancer Compounds

Introduction

Suresh Paidakula is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer agents. With a total of 4 patents, his work focuses on innovative compounds that have the potential to combat human cancer cell lines.

Latest Patents

Among his latest patents, Suresh has developed compounds such as Amidobenzothiazoles, which are designed as potential anti-cancer agents. This invention provides a compound of general formulae A, useful against various human cancer cell lines. Additionally, he has patented 4-Aza-2,3-didehydropodophyllotoxin compounds, which are also aimed at serving as effective antitumor agents. The process for synthesizing these compounds is a significant advancement in cancer treatment research.

Career Highlights

Suresh Paidakula is affiliated with the Council of Scientific and Industrial Research, where he continues to engage in groundbreaking research. His work has not only contributed to the scientific community but has also paved the way for potential therapeutic applications in oncology.

Collaborations

Suresh has collaborated with notable colleagues such as Kamal Ahmed and Ashwini Kumar Banala. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Suresh Paidakula stands out as an influential inventor in the field of anti-cancer research. His innovative patents and collaborations reflect his commitment to advancing medical science and improving treatment options for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…